Good afternoon, everyone, and welcome to our fourth quarter 2025 earnings call. Bob Bradway will lead the call today and be ...
Amgen Inc. (NASDAQ:AMGN) is included among the 15 Best S&P 500 Dividend Stocks to Buy in 2026. On January 20, Bernstein ...
The California-based biotech company's quarterly revenue rose 9% from a year earlier to $9.9 billion, which beat the average ...
StockStory.org on MSN
AMGN Q4 deep dive: Product portfolio expansion and pipeline progress drive outlook
Biotech company Amgen (NASDAQ:AMGN) in Q4 CY2025, with sales up 8.6% year on year to $9.87 billion. The company’s full-year ...
The Manila Times on MSN
Amgen's Q4 results beat expectations, shares rise modestly
AMGEN on Tuesday reported fourth-quarter financial results that came in ahead of Wall Street expectations, sending its shares modestly higher as the company continues to express confidence in ...
Amgen’s (AMGN) fourth-quarter earnings on Tuesday will have investors looking out for developments around the company’s ...
Amgen (NASDAQ:AMGN) executives highlighted broad-based growth in 2025 and laid out expectations for continued momentum in ...
Combat hyperpigmentation, dry skin, and more.
Bring on the pigment.
Pennsylvania field trials identify three herbicides providing 95% to 99% control of smooth bedstraw in established grass hayfields.
RFK Jr. says TrumpRX will launch "probably in the next 10 days." What we know about how buying medicine, getting discounts on ...
Amgen Inc. reports fourth-quarter earnings today after the bell, putting the spotlight on how the $185.6 billion biotechnology giant plans to navigate a year marked by significant biosimilar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results